Addex Therapeutics Ltd ADXN

SWX: ADXN | ISIN: CH0029850754   17/05/2024
0,068 CHF (+5,59%)
(+5,59%)   17/05/2024

8 mei 2024 · Addex to Present at Bio€quity Europe 2024 · Persbericht

29 april 2024 · Addex Provides Update on ADX71149 Phase 2 Epilepsy Study · Persbericht

19 april 2024 · Addex to Present at the Swiss Biotech Day 2024 · Persbericht

18 april 2024 · Addex Therapeutics Reports Full Year 2023 Financial Results and Provides Corporate Update · Persbericht

11 april 2024 · Addex Therapeutics to Release Full-Year 2023 Financial Results and Host Conference Call on April 18, 2024 · Persbericht

3 april 2024 · Addex and Perceptive Launch Neurosterix with $63 Million to Accelerate Development of Allosteric Modulator Therapeutics for Neurological Disorders · Persbericht

14 maart 2024 · Addex to Present at the Bio-Europe Spring 2024 Conference · Persbericht

31 januari 2024 · Addex Enters into At-The-Market ADS Offering Agreement with H.C. Wainwright & Co. LLC. · Persbericht

9 januari 2024 · Addex to Present at the Swiss Equities Baader Conference · Persbericht

5 januari 2024 · Addex to Present at Biotech Showcase™ 2024 · Persbericht

20 december 2023 · Addex Shareholders Approve All Resolutions at Extraordinary General Meeting · Persbericht

14 december 2023 · Addex Creates Treasury Shares · Persbericht

29 november 2023 · Addex Reports Q3 2023 Financial Results and Provides Corporate Update · Persbericht

28 november 2023 · Addex Convenes Extraordinary General Meeting · Persbericht

23 november 2023 · Addex Therapeutics to Release Third Quarter 2023 Financial Results and Host Conference Call on November 29, 2023 · Persbericht

14 november 2023 · Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment of Patients · Persbericht

8 november 2023 · Addex Regains Nasdaq Listing Compliance · Persbericht

2 november 2023 · Addex Announces Participation in the Bio-Europe 2023 Conference · Persbericht

20 oktober 2023 · Addex Completes ADS Ratio Change · Persbericht

6 oktober 2023 · Addex Announces Plan to Implement ADS Ratio Change · Persbericht

Mijn selecties